These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34369147)
21. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand. Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099 [TBL] [Abstract][Full Text] [Related]
22. Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion. Xie L; Wang L; Guan R; Ji L; Chao H J Inorg Biochem; 2021 Apr; 217():111380. PubMed ID: 33578250 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, DNA interaction, antioxidant and anticancer activity studies of ruthenium(II) polypyridyl complexes. Jiang GB; Xie YY; Lin GJ; Huang HL; Liang ZH; Liu YJ J Photochem Photobiol B; 2013 Dec; 129():48-56. PubMed ID: 24177204 [TBL] [Abstract][Full Text] [Related]
24. Ruthenium(II) complexes: DNA-binding, cytotoxicity, apoptosis, cellular localization, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential and western blot analysis. Li W; Jiang GB; Yao JH; Wang XZ; Wang J; Han BJ; Xie YY; Lin GJ; Huang HL; Liu YJ J Photochem Photobiol B; 2014 Nov; 140():94-104. PubMed ID: 25108205 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru(II) arene complexes with benzoylthiourea derivatives. Obradović D; Nikolić S; Milenković I; Milenković M; Jovanović P; Savić V; Roller A; Đorđić Crnogorac M; Stanojković T; Grgurić-Šipka S J Inorg Biochem; 2020 Sep; 210():111164. PubMed ID: 32634653 [TBL] [Abstract][Full Text] [Related]
26. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
28. Dual-targeting organometallic ruthenium(II) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands. Zhang Y; Zheng W; Luo Q; Zhao Y; Zhang E; Liu S; Wang F Dalton Trans; 2015 Aug; 44(29):13100-11. PubMed ID: 26106875 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells. Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660 [TBL] [Abstract][Full Text] [Related]
30. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424 [TBL] [Abstract][Full Text] [Related]
31. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390 [TBL] [Abstract][Full Text] [Related]
32. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling. Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850 [TBL] [Abstract][Full Text] [Related]
34. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway. Chen L; Wang J; Cai X; Chen S; Zhang J; Li B; Chen W; Guo X; Luo H; Chen J Bioorg Chem; 2022 Feb; 119():105516. PubMed ID: 34856444 [TBL] [Abstract][Full Text] [Related]
35. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation. Cunha BN; Luna-Dulcey L; Plutin AM; Silveira RG; Honorato J; Cairo RR; de Oliveira TD; Cominetti MR; Castellano EE; Batista AA Inorg Chem; 2020 Apr; 59(7):5072-5085. PubMed ID: 32208661 [TBL] [Abstract][Full Text] [Related]
36. Significant effects of counteranions on the anticancer activity of iridium(iii) complexes. Zhang H; Guo L; Tian Z; Tian M; Zhang S; Xu Z; Gong P; Zheng X; Zhao J; Liu Z Chem Commun (Camb); 2018 Apr; 54(35):4421-4424. PubMed ID: 29648559 [TBL] [Abstract][Full Text] [Related]
37. New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent. Guerriero A; Oberhauser W; Riedel T; Peruzzini M; Dyson PJ; Gonsalvi L Inorg Chem; 2017 May; 56(10):5514-5518. PubMed ID: 28443659 [TBL] [Abstract][Full Text] [Related]
38. Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells. Pracharova J; Novohradsky V; Kostrhunova H; Štarha P; Trávníček Z; Kasparkova J; Brabec V Dalton Trans; 2018 Sep; 47(35):12197-12208. PubMed ID: 30112527 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption. Wan D; Tang B; Wang YJ; Guo BH; Yin H; Yi QY; Liu YJ Eur J Med Chem; 2017 Oct; 139():180-190. PubMed ID: 28800456 [TBL] [Abstract][Full Text] [Related]
40. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells. Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]